Researches at Columbia University in New York City have developed eye drops that have the potential of being more effective and viewed as a comfortable therapy for RVO (retinal vein occlusion). RVO affects up to 2% of people over...read more
A study recently conducted by the Penn Medical Center for Genetics of Complex Disease funded by the National Institutes of Health gained new insights from previously unknown inherited genetic variants that contribute to primary open-angle glaucoma (POAG). POGA is...read more
/ 53 Reviews